Insider Ledger
DRMA insider buying and SEC filings, explained
Dermata Therapeutics, Inc. · CIK 1853816
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- Dermata Therapeutics, Inc.
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$13
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 16, 2026 | Sale | Kathleen D. Scott (Director) sold 11 shares at $1.19 ($13). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 16, 2026 |
| Feb 17, 2026 | Purchase (code P) | Munera Maria E Bedoya-Toro (SVP, Regulatory Affairs) bought 1,000 shares at $1.27 ($1K), reported as a purchase (code P). Holdings up 999%+ to 1,012 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 17, 2026 |
15 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Oct 29, 2026, 5:26 PM ET 8-K | Other event (Item 8.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow DRMA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.